Clinical Research Directory
Browse clinical research sites, groups, and studies.
Rocklatan Retinal Perfusion OCT Study
Sponsor: Oregon Health and Science University
Summary
The main purpose of this study is to learn more about how Rocklatan eye drops affects blood flow in the eye. The secondary purpose is to see if our study devices can detect changes in blood flow before and after instillation of Rocklatan.
Official title: Rocklatan Trial With Optical Coherence Tomography Study of Retinal Perfusion
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-01
Completion Date
2027-10
Last Updated
2025-12-24
Healthy Volunteers
No
Conditions
Interventions
Rocklatan eye drops will be instilled nightly in one eye diagnosed with glaucoma for up to 12 months.
The eye not selected as the study eye will be used for comparison so both eyes will be imaged with the study devices to assess blood flow changes.
Two optical coherence tomography (OCT) devices will be used to assess blood flow changes.
One OCT device is FDA-cleared while the other is still experimental. Both devices assess blood flow in different ways.
Locations (1)
Casey Eye Institute - Oregon Health & Science University
Portland, Oregon, United States